Cormorant Asset Management LP 13D and 13G filings for EyePoint Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 3:10 pm Purchase | 2024-09-30 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | Cormorant Asset Management LP | 8,325,000 12.200% | 2,286,765 (+37.87%) | Filing |
| 2023-12-14 4:04 pm Purchase | 2023-12-04 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | Cormorant Asset Management LP | 6,038,235 12.360% | 6,038,235 (New Position) | Filing |